Sep 27, 2018 - Acadia is pretty much a one-therapy company under development for a variety of critical applications.The one FDA-approved indication for Acadia's key therapy, NUPLAZID (pimavanserin), has been under s
Sep 26, 2018 - Data read-outs by quite a few companies grabbed headlines in the biotech sector this week.
Aug 23, 2018 - Dropbox has a great business model.Amgen is cheap compared to Acadia Pharmaceuticals.XPO Logistics is a buy.
Aug 11, 2018 - Possible future competitor to Minerva, Acadia reported decreasing growth visibility and uptake for their drug, Nuplazid.This is likely attributed to recent and relevant safety concerns raised surround
Aug 08, 2018 - The
S&P 500 finished Wednesday slightly lower, ending its four-session winning
streak with an uneven
Jul 17, 2018 - The biotechnology sector is fertile ground for highly profitable investments, but the downside risk in the sector is also above average.Since the dispersion in returns is so wide, picking the right in
Jul 13, 2018 - Which stock wins in a battle between a small, beaten-down biotech and an established major drugmaker?
Jul 12, 2018 - How technology changes human behavior and social rules, but not human nature and genetics???yet.
Jul 11, 2018 - Steven Cohen Powers Into C&J Energy Services, Stocks: CJ,CBIO,PAGS,ACAD, Steven Cohen, release date:Jul 11, 2018
Jul 09, 2018 - 3 Stocks Move Monday, Stocks: ACAD,DLPH,PFE, release date:Jul 09, 2018